Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis
about
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemiaAntifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.Aspergillus fumigatus and aspergillosisLipid-based amphotericin B for the treatment of fungal infections.Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion.A comparative review of conventional and lipid formulations of amphotericin B.Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy.Carrier effects on biological activity of amphotericin B.Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products.Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosis.Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbitsAnimal Models for Studying Triazole Resistance in Aspergillus fumigatus.Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.
P2860
Q28349552-68405CDB-3BAE-416C-8881-E1C1C74A306DQ28369150-AC54658B-2788-4825-842C-36A202784890Q29617908-8CA5FD22-49C4-41E8-ACA3-01426951A8A5Q33604227-65CE7316-8DB9-4ABA-AF36-FA490643C926Q33691165-9A2C780B-1C04-4541-8B62-A74378A1418DQ33727839-C226C756-CC0A-4EA8-B500-B28402A3B337Q33978764-7A1B9019-437B-4774-A31A-63E003DF479AQ33978902-17F9F9CB-205D-4E5C-B310-3F409E7859A2Q33983629-9C534916-5064-481E-8288-E95B6446CFE8Q34251910-6B589412-795A-4F96-AA9B-87D8F16223C0Q34294904-318F7B7A-198C-46EE-B9C6-B1878EA1BBC7Q35091593-AB012CCE-497B-4232-8CF7-3FE44CDB46CBQ35114249-77F05BF8-3F98-4683-ADB6-AC4D4127DFB5Q35372581-56F3C3BE-6716-4EE9-895A-3D80DBD7D9FDQ36422661-EB86956C-C17D-49CA-BDB1-00532E24B642Q36489697-52BC4C55-808C-4743-AD02-820529B5493AQ39476373-DED85F41-661D-4F54-A523-AA2B0AE826FEQ40045642-A8EB58B3-0F50-4605-A70F-1D0EF7A869AFQ44453839-F24D7130-0E1F-4DC0-BB47-60A91EF60278
P2860
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@ast
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@en
type
label
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@ast
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@en
prefLabel
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@ast
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@en
P2093
P2860
P356
P1476
Dose-dependent antifungal acti ...... mental pulmonary aspergillosis
@en
P2093
Allende MC
Berenguer J
Dollenberg H
P2860
P304
P356
10.1128/AAC.38.3.518
P407
P577
1994-03-01T00:00:00Z